EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Toll-like Receptor 2 Recognition of Microbiota Lipoproteins and Lipids in Immunity and Therapy

Xing Zhang iD, Natavan Dudkina iD, Adrianna M Turner, Howard C Hang iD

ACS Chemical Biology · 2026

DOI: 10.1021/acschembio.6c00498 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift ACS Chemical Biology, 2026. Verfasst von Xing Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology and Microbiology, Scripps Research, La Jolla, California92037, United States. Hauptthemen laut MEDLINE: Toll-Like Receptor 2, Lipoproteins, Microbiota, Lipids. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 80 Literaturangaben. Gefördert von: California Institute for Regenerative Medicine, Helen Hay Whitney Foundation, Scripps Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Toll-like receptor 2 (TLR2) recognizes a remarkably diverse range of microbial molecules and plays central roles in host defense, immune homeostasis, and cancer immunotherapy. Although bacterial lipoproteins and lipopeptides are canonical TLR2 agonists, recent studies have identified additional microbiota-derived ligands, including lipids, proteins, and polysaccharides. Advances in chemical biology, structural analysis, and activity-guided fractionation have revealed how subtle variations in ligand architecture influence TLR2 heterodimer usage, downstream signaling, and context-dependent immune outcomes. In this review, we summarize current knowledge of microbiota-derived TLR2 ligands and discuss recent progress in synthetic TLR2 agonists. We further highlight how ligand structure, receptor heterodimerization, and cellular context collectively shape TLR2-mediated immune responses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Toll-Like Receptor 2LipoproteinsMicrobiotaLipidsHumansAnimalsLigandsToll-Like Receptor AgonistsInnate Immunity RecognitionLipopeptidesSignal Transduction

Substanzen

Toll-Like Receptor 2LipoproteinsLigandsLipidsToll-Like Receptor AgonistsLipopeptides

Autor:innen und Institutionen

  • Department of Immunology and Microbiology, Scripps Research, La Jolla, California92037, United States.
  • Department of Chemistry, Scripps Research, La Jolla, California92037, United States.

ORCID-Profile: Xing Zhang, Natavan Dudkina, Howard C Hang

Förderung

  • California Institute for Regenerative Medicine
  • Helen Hay Whitney Foundation
  • Scripps Research
  • George E. Hewitt Foundation for Medical Research

Zitieren

APA

Zhang, X., Dudkina, N., Turner, A. M., & Hang, H. C. (2026). Toll-like Receptor 2 Recognition of Microbiota Lipoproteins and Lipids in Immunity and Therapy. ACS Chemical Biology. https://doi.org/10.1021/acschembio.6c00498

Vancouver

Zhang X, Dudkina N, Turner AM, Hang HC. Toll-like Receptor 2 Recognition of Microbiota Lipoproteins and Lipids in Immunity and Therapy. ACS Chemical Biology. 2026. doi:10.1021/acschembio.6c00498

BibTeX
@article{Zhang2026,
  author = {Zhang, Xing and Dudkina, Natavan and Turner, Adrianna M and Hang, Howard C},
  title = {Toll-like Receptor 2 Recognition of Microbiota Lipoproteins and Lipids in Immunity and Therapy},
  journal = {ACS Chemical Biology},
  year = {2026},
  doi = {10.1021/acschembio.6c00498}
}
Kostenlos starten →